ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasound.
Date
2020-06-01ICR Author
Author
Abramowicz, JS
Basseal, JM
Brezinka, C
Dall'Asta, A
Deng, J
Harrison, G
Lee, JCS
Lim, A
Maršal, K
Miloro, P
Poon, LC
Salvesen, KÅ
Sande, R
Ter Haar, G
Westerway, SC
Xie, MX
Lees, C
Type
Journal Article
Metadata
Show full item recordCollections
Subject
COVID-19
Coronavirus Infections
Equipment Contamination
Eye Protective Devices
Female
Gloves, Protective
Gynecology
Hand Hygiene
Health Personnel
Humans
Infectious Disease Transmission, Patient-to-Professional
Infectious Disease Transmission, Professional-to-Patient
Masks
Mass Screening
Obstetrics
Pandemics
Personal Protective Equipment
Pneumonia, Viral
Pregnancy
Respiratory Protective Devices
Triage
Ultrasonography
Ultrasonography, Prenatal
Ventilation
Research team
Therapeutic Ultrasound
Language
eng
Date accepted
2020-06-01
License start date
2020-06-01
Citation
Ultrasound in Obstetrics and Gynecology, 2020, 55 (6), pp. 886 - 891
Publisher
WILEY
Related items
Showing items related by title, author, creator and subject.
-
Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747).
Andronis, L; Goranitis, I; Pirrie, S; Pope, A; Barton, D; et al. (2017-04)Objective To evaluate the cost-effectiveness of adding zoledronic acid or strontium-89 to standard docetaxel chemotherapy for patients with castrate-refractory prostate cancer (CRPC).Patients and methods Data on resource ... -
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.
Scott, RA; Freitag, DF; Li, L; Chu, AY; Surendran, P; et al. (AMER ASSOC ADVANCEMENT SCIENCE, 2016-06-01)Regulatory authorities have indicated that new drugs to treat type 2 diabetes (T2D) should not be associated with an unacceptable increase in cardiovascular risk. Human genetics may be able to guide development of antidiabetic ... -
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study.
Adams, CD; Richmond, R; Ferreira, DLS; Spiller, W; Tan, V; et al. (AMER ASSOC CANCER RESEARCH, 2019-01-01)BACKGROUND: Whether associations between circulating metabolites and prostate cancer are causal is unknown. We report on the largest study of metabolites and prostate cancer (2,291 cases and 2,661 controls) and appraise ...